ERBB2 and breast cancer: In light of our observation that mice bearing fully regressed HER2/neu or Wnt1 mammary tumors eventually develop spontaneous tumor recurrences when maintained off doxycycline [17, 18], we considered the possibility that residual tumor cells might be enriched for TICs capable of giving rise to recurrent, rather than primary, tumors.